4.6 Article

Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study

Journal

Publisher

ELSEVIER
DOI: 10.1016/j.ejps.2019.105063

Keywords

Proticles; PEGylation; SPECT imaging; in vivo pharmacokinetics

Funding

  1. Austrian Nano-Initiative [0200]
  2. Austrian FWF (Fonds zur Forderung der Wissenschaftlichen Forschung) [N208-NAN, N203-NAN]
  3. Tiroler Wissenschaftsfond [UNI-0404/417]

Ask authors/readers for more resources

The development of so-called Proticles opens attractive possibilities for new drug delivery systems. Proticles are nanoparticles (NPs), which are formed by self-assembly of negatively charged oligonucleotides in combination with the positively charged peptide protamine. Polyethylene glycol (PEG) is a widely known pharmaceutical agent to stop particle growth and prolong circulation half-life of drug delivery systems. Therefore, two different NP formulations - one PEGylated and one non-PEGylated - were used in this work to gain information about the biological stability and half-life in circulation of Proticles. Thus, this study presents data of in vitro stability and in vivo pharmacokinetics of both, non-PEGylated and PEGylated Proticles radiolabeled with (InCl3)-In-111. The study demonstrated that successful radiolabeling of both Proticle-formulations was performed resulting in high radiochemical yields (> 85 %). Furthermore, the influence of PEGylation on the in vitro stability of (111)Inradiolabeled NPs was investigated. No significant difference due to PEGylation was found. Unlike in vitro results, non-PEGylated In-111-Proticles seemed to degrade faster in vivo than PEGylated In-111-proticles, resulting in significantly higher blood values (In-111-PEG-proticles: 0.23 +/- 0.01 % ID/g 1 h p.i.; In-111-proticles: 0.06 +/- 0.01 % ID/g 1 h p.i.; p < 0.05). Visualized by SPECT imaging urinary excretion represented the major pathway of elimination for both NP-formulations. In conclusion, this study provides data indicating a positive influence of PEG-derivatization on the biodistribution and pharmacokinetics of Proticles. These results form the basis for further developments as drug delivery and active drug targeting devices.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available